FIELD: medicine.
SUBSTANCE: invention refers to medicine, namely to phthisiology, particularly to treating pulmonary tuberculosis with multiple drug-resistance of tuberculosis mycobacteria. That is ensured by the intramedular drop introduction of the anti-tuberculosis preparations for 1 week, then intramuscular introduction of Derinat 5 ml once per day every 48 hours, course of 10 injections, as well as inhalations through the nebuliser once a day with a mixture of Derinate with physiologic saline at ratio of 1:1 (2 ml of Derinat and 2 ml of saline), course – 20 procedures.
EFFECT: invention provides higher clinical effectiveness in pulmonary tuberculosis with multiple drug-resistance of tuberculosis mycobacteria in early stages.
1 cl, 2 dwg, 1 tbl, 1 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF TREATING BRONCHIAL TUBERCULOSIS IN PATIENTS WITH LUNG TUBERCULOSIS WITH A MULTIDRUG RESISTANCE / EXTENSIVELY DRUG RESISTANCE OF DISEASE CAUSATIVE AGENT | 2019 |
|
RU2727760C1 |
| METHOD OF TREATING PULMONARY AND BRONCHIAL TUBERCULOSIS IN VARIOUS X-RAY SYNDROMES | 2023 |
|
RU2826098C1 |
| METHOD FOR TREATING HUMAN TUBERCULOSIS | 2002 |
|
RU2238091C2 |
| METHOD FOR SELECTING SHORTENED CHEMOTHERAPY REGIMENS FOR THE TREATMENT OF PULMONARY TUBERCULOSIS | 2022 |
|
RU2805496C1 |
| METHOD FOR TREATMENT OF PULMONARY TUBERCULOSIS | 2003 |
|
RU2243776C1 |
| METHOD FOR FORMATION OF SHORTENED REGIMENS OF CHEMOTHERAPY FOR RESPIRATORY TUBERCULOSIS WITH MULTIPLE AND EXTENSIVE DRUG RESISTANCE OF MBT IN OLDER CHILDREN AND ADOLESCENTS | 2020 |
|
RU2748957C1 |
| METHOD FOR FORMING A CHEMOTHERAPY REGIMEN FOR PRIMARY INTRATHORACIC TUBERCULOSIS IN CHILDREN FROM TUBERCULOSIS INFECTION CENTERS | 2018 |
|
RU2704816C1 |
| METHOD FOR DIAGNOSING AND TREATING BRONCHIAL HYPERACTIVITY IN SMOKERS AND NON-SMOKERS WITH PULMONARY TUBERCULOSIS | 2023 |
|
RU2822712C1 |
| METHOD OF TREATING PATIENTS WITH DESTRUCTIVE FORMS OF PULMONARY TUBERCULOSIS | 2015 |
|
RU2587332C1 |
| METHOD FOR APPLICATION YAGEL DETOX DIETARY SUPPLEMENT AS MEANS FOR TREATMENT OF MULTIPLE DRUG RESISTANCE TUBERCULOSIS | 2017 |
|
RU2673555C2 |
